These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 20471559)

  • 1. Immunohistochemical study of syndecan-1 down-regulation and the expression of P35 protein in oral lichen planus: a clinicopathologic correlation with hepatitis C infection in the Egyptian population.
    Zyada MM; Fikry HE
    Ann Diagn Pathol; 2010 Jun; 14(3):153-61. PubMed ID: 20471559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical study on topoisomerase IIalpha, Ki-67 and cytokeratin-19 in oral lichen planus lesions.
    Mattila R; Alanen K; Syrjänen S
    Arch Dermatol Res; 2007 Jan; 298(8):381-8. PubMed ID: 17072627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No differences in caspase-3 and Bax expression in atrophic-erosive vs. reticular oral lichen planus.
    Bascones-Ilundain C; González-Moles MA; Campo-Trapero J; Gil-Montoya JA; Esparza-Gómez GC; Cano-Sánchez J; Bascones-Martínez A
    J Eur Acad Dermatol Venereol; 2008 Feb; 22(2):204-12. PubMed ID: 18211414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of proliferative potential in oral lichen planus and oral lichenoid lesions using immunohistochemical expression of p53 and Ki67.
    Acay RR; Felizzola CR; de Araújo N; de Sousa SO
    Oral Oncol; 2006 May; 42(5):475-80. PubMed ID: 16364678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology, etiologic factors, and clinical management of oral lichen planus, part I: facts and controversies.
    Farhi D; Dupin N
    Clin Dermatol; 2010; 28(1):100-8. PubMed ID: 20082959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective five-year follow-up study of 192 patients.
    van der Meij EH; Mast H; van der Waal I
    Oral Oncol; 2007 Sep; 43(8):742-8. PubMed ID: 17112770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The oral lichen planus: doubts and evidence].
    Tar I; Márton I
    Fogorv Sz; 2009 Jun; 102(3):103-9. PubMed ID: 19618778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neoplastic transformation of oral lichen planus. II: association with risk co-factors].
    Vescovi P; Manfredi M; Savi A; Bonanini M
    Minerva Stomatol; 2000 May; 49(5):257-66. PubMed ID: 11068423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of anti-HCV among patients with oral lichen planus in Southern Taiwan.
    Lin LH; Lu SY; Lu SN
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):408-14. PubMed ID: 20097108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher expressions of p53 and proliferating cell nuclear antigen (PCNA) in atrophic oral lichen planus and patients with areca quid chewing.
    Lee JJ; Kuo MY; Cheng SJ; Chiang CP; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Apr; 99(4):471-8. PubMed ID: 15772596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Fas/FasL in patients with oral lichen planus.
    Hadzi-Mihailovic M; Raybaud H; Monteil R; Jankovic L
    J BUON; 2009; 14(3):487-93. PubMed ID: 19810143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus chronic infection and oral lichen planus: an Italian case-control study.
    Giuliani M; Lajolo C; Miani MC; Lodi G; Minenna P; Mangia A
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):647-52. PubMed ID: 17625433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bcl-2 expression and its possible influence on malignant transformation of oral lichen planus.
    Hadzi-Mihailovic M; Raybaud H; Monteil R; Cakic S; Djuric M; Jankovic L
    J BUON; 2010; 15(2):362-8. PubMed ID: 20658736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COX-2 expression in oral lichen planus.
    Lysitsa S; Samson J; Gerber-Wicht C; Lang U; Lombardi T
    Dermatology; 2008; 217(2):150-5. PubMed ID: 18536521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HCV infection and oral lichen planus: a weak association when HCV is endemic.
    Campisi G; Fedele S; Lo Russo L; Di Fede O; Aricò P; Craxì A; Mignogna MD
    J Viral Hepat; 2004 Sep; 11(5):465-70. PubMed ID: 15357654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical study of 674 patients with oral lichen planus in China.
    Xue JL; Fan MW; Wang SZ; Chen XM; Li Y; Wang L
    J Oral Pathol Med; 2005 Sep; 34(8):467-72. PubMed ID: 16091113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update of the cancer-associated molecular mechanisms in oral lichen planus, a disease with possible premalignant nature.
    Georgakopoulou EA; Troupis TG; Troupis G; Gorgoulis VG
    J BUON; 2011; 16(4):613-6. PubMed ID: 22331711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of the expression of proliferating cell nuclear antigen, p53, bax, and bcl-2 in oral lichen planus and oral squamous cell carcinoma.
    de Sousa FA; Paradella TC; Carvalho YR; Rosa LE
    Ann Diagn Pathol; 2009 Oct; 13(5):308-12. PubMed ID: 19751907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between hepatitis C virus infection and oral lichen planus in Israeli patients.
    Yarom N; Dagon N; Shinar E; Gorsky M
    Isr Med Assoc J; 2007 May; 9(5):370-2. PubMed ID: 17591375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of the p63 related proteins beta-catenin, E-cadherin and EGFR in oral lichen planus.
    Ebrahimi M; Boldrup L; Wahlin YB; Coates PJ; Nylander K
    Oral Oncol; 2008 Jul; 44(7):634-8. PubMed ID: 17936670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.